Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders
1 other identifier
observational
68
1 country
1
Brief Summary
Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2023
CompletedFirst Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 21, 2025
CompletedMay 21, 2025
May 1, 2025
1.5 years
May 5, 2025
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Oxidative stress markers
Total antioxidant status (μmol Trolox equivalent/ L)
From January 2020 to Jun 2021
Oxidative stress markers
Total oxidant status (μmol H2O2 equivalent/L)
From January 2020 to Jun 2021
Oxidative stress markers
Paraoxonase (U/L)
From January 2020 to Jun 2021
Oxidative stress markers
Arylesterase (Ku/l)
From January 2020 to Jun 2021
Oxidative stress markers
Total thiol (µmol / L)
From January 2020 to Jun 2021
Oxidative stress markers
Native thiol (µmol / L) / alb (g / l)
From January 2020 to Jun 2021
Oxidative stress markers
Disulfide (-S-S-) (µmol / L) / alb (g/l)
From January 2020 to Jun 2021
Oxidative stress markers
Ischemia-modified albumin (u/L)
From January 2020 to Jun 2021
Oxidative stress markers
Oxidative stress index (arbitrary unit)
From January 2020 to Jun 2021
Study Arms (2)
Autism spectrum disorders
38 individuals with autism spectrum disorders
Control
30 healthy individuals
Eligibility Criteria
The study included children who visited the Child and Adolescent Psychiatry and Adolescent Pediatric Gastroenterology outpatient clinics.
You may qualify if:
- Healthy children who applied to the pediatric clinic for routine examination
You may not qualify if:
- Children who have any chronic medical diseases or psychiatric disorders
- Children who have a family history of chronic medical diseases or psychiatric disorders
- Children with autism spectrum disorder (Diagnosis based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR))
- Children who have a family history of chronic medical diseases or psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mardin Artuklu Universitylead
- Alanya Alaaddin Keykubat Universitycollaborator
Study Sites (1)
Alanya Training and Research Hospital
Antalya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 5, 2025
First Posted
May 21, 2025
Study Start
January 3, 2020
Primary Completion
June 30, 2021
Study Completion
January 30, 2023
Last Updated
May 21, 2025
Record last verified: 2025-05